Vasodilators in aortic regurgitation - Where is the evidence of their effectiveness?

New England Journal of Medicine

Volumn 353, Issue 13, 2005, Pages 1400-1402

  Carabello, Blase A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; ENALAPRIL; NIFEDIPINE; PLACEBO; VASODILATOR AGENT;

AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; BLOOD PRESSURE; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED MEDICINE; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART WORK; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

AORTIC VALVE INSUFFICIENCY; ENALAPRIL; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; NIFEDIPINE; TREATMENT FAILURE; VASODILATOR AGENTS;

EID: 25444471518     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe058213     Document Type: Editorial

References (13)

1. Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol 1984;3:916-23.
2. Taniguchi K, Nakano S, Kawashima Y, et al. Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation 1990;82:798-807.
3. Carabello BA. Aortic regurgitation: a lesion with similarities to both aortic stenosis and mitral regurgitation. Circulation 1990;82:1051-3.
4. Greenberg BH, Massie B, Bristow JD, et al. Long-term vasodilator therapy of chronic aortic insufficiency: a randomized double-blinded, placebo-controlled clinical trial. Circulation 1988;78:92-103.
5. Schon HR, Dorn R, Barthel P, Schomig A. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation. J Heart Valve Dis 1994;3:500-9.
6. Sondergaard L, Aldershvile J, Hildebrandt P, Kelbaek H, Stahlberg F, Thomsen C. Vasodilatation with felodipine in chronic asymptomatic aortic regurgitation. Am Heart J 2000;139:667-74.
7. Fioretti P, Benussi B, Scardi S, Klugmann S, Brower RW, Camerini F. Afterload reduction with nifedipine in aortic insufficiency. Am J Cardiol 1982;49:1728-32.
8. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994;331:689-94.
9. Scognamiglio R, Negut CH, Palisi M, Fasoli G, Dalla-Volta S. Long-term survival and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction. J Am Coll Cardiol 2005;45:1025-30.
10. Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005;353:1342-9.
11. Scognamiglio R, Fasoli G, Ponchia A, Dalla-Volta S. Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990;16:424-9.
12. Kloner RA, Birnbaum Y, eds. Cardiovascular trials review. 9th ed. Darien, Conn.: Le Jacq, 2004.
13. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1486-588.